Find Prulifloxacin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 123447-62-1, Pruvel, Nm441, Quisnon, Nm-441, Prulifloxacin [inn]
Molecular Formula
C21H20FN3O6S
Molecular Weight
461.5  g/mol
InChI Key
PWNMXPDKBYZCOO-UHFFFAOYSA-N
FDA UNII
J42298IESW

Prulifloxacin
Prulifloxacin has been investigated for the treatment of Urinary Tract Infection.
1 2D Structure

Prulifloxacin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxo-1H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid
2.1.2 InChI
InChI=1S/C21H20FN3O6S/c1-10-16(31-21(29)30-10)9-23-3-5-24(6-4-23)15-8-14-12(7-13(15)22)18(26)17(20(27)28)19-25(14)11(2)32-19/h7-8,11H,3-6,9H2,1-2H3,(H,27,28)
2.1.3 InChI Key
PWNMXPDKBYZCOO-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCN(CC4)CC5=C(OC(=O)O5)C
2.2 Other Identifiers
2.2.1 UNII
J42298IESW
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 6-fluoro-1-methyl-7-(4-(5-methyl-2-oxo-1,3-dioxelen-4-yl)methyl-1-piperazinyl)-4-oxo-4h-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic Acid

2. Nm 441

3. Nm-441

4. Nm441

2.3.2 Depositor-Supplied Synonyms

1. 123447-62-1

2. Pruvel

3. Nm441

4. Quisnon

5. Nm-441

6. Prulifloxacin [inn]

7. Sword

8. Nm 441

9. Prulifloxacin (hydrochloride)

10. 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic Acid

11. J42298iesw

12. Nsc-759833

13. 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl]-4-oxo-1h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic Acid

14. Ncgc00164615-01

15. Prulifloxacin 100 Microg/ml In Acetonitrile

16. Dsstox_cid_26480

17. Dsstox_rid_81651

18. Dsstox_gsid_46480

19. 1h,4h-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic Acid, 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)-1-piperazinyl)-4-oxo-

20. 1h,4h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic Acid, 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-

21. 6-fluoro-1-methyl-7-(4-((5-methyl-2-oxo-1,3-dioxol-4-yl)methyl)piperazin-1-yl)-4-oxo-1h,4h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic Acid

22. Ccris 7686

23. Cas-123447-62-1

24. Unii-j42298iesw

25. Pufloxacin Dioxolil

26. 6-fluoro-1-methyl-7-{4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-1-yl}-4-oxo-4h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic Acid

27. Prulifloxacin [mi]

28. Prulifloxacin [jan]

29. Mls006011767

30. Prulifloxacin [mart.]

31. Prulifloxacin [who-dd]

32. Chembl422648

33. Nad-441a

34. Opt-99

35. Schembl1650794

36. Dtxsid0046480

37. Chebi:32071

38. Bcp12727

39. Hy-b0024

40. Tox21_112235

41. Bbl034010

42. Mfcd00864847

43. S2071

44. Stk626148

45. Akos005559236

46. Nm441;af 3013

47. Prulifloxacin (nm441, Af 3013)

48. Tox21_112235_1

49. Ac-2012

50. Af 3012

51. Db11892

52. Nsc 759833

53. Sb18983

54. Ncgc00164615-02

55. Ncgc00164615-03

56. (+-)-7-(4-((z)-2,3-dihydroxy-2-butenyl)-1-piperazinyl)-6-fluoro-1-methyl-4-oxo-1h,4h-(1,3)thiazeto(3,2-a)quinoline-3-carboxylic Acid, Cyclic Carbonate

57. As-13607

58. Smr000046722

59. Ft-0651733

60. P2058

61. F20576

62. 447p621

63. Prulifloxacin, >=98% (perchloric Acid Titration)

64. Sr-01000872596

65. Prulifloxacin, Antibiotic For Culture Media Use Only

66. Q-101929

67. Q3924793

68. Sr-01000872596-1

69. Brd-a92341659-001-01-6

70. 6-fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]piperazin-4-ium-1-yl]-4-oxo-1h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 461.5 g/mol
Molecular Formula C21H20FN3O6S
XLogP31
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count11
Rotatable Bond Count4
Exact Mass461.10568470 g/mol
Monoisotopic Mass461.10568470 g/mol
Topological Polar Surface Area125 Ų
Heavy Atom Count32
Formal Charge0
Complexity931
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


Topoisomerase II Inhibitors

Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)


4.2 ATC Code

J - Antiinfectives for systemic use

J01 - Antibacterials for systemic use

J01M - Quinolone antibacterials

J01MA - Fluoroquinolones

J01MA17 - Prulifloxacin


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Prulifloxacin Manufacturers

A Prulifloxacin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prulifloxacin, including repackagers and relabelers. The FDA regulates Prulifloxacin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prulifloxacin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Prulifloxacin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Prulifloxacin Suppliers

A Prulifloxacin supplier is an individual or a company that provides Prulifloxacin active pharmaceutical ingredient (API) or Prulifloxacin finished formulations upon request. The Prulifloxacin suppliers may include Prulifloxacin API manufacturers, exporters, distributors and traders.

click here to find a list of Prulifloxacin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Prulifloxacin USDMF

A Prulifloxacin DMF (Drug Master File) is a document detailing the whole manufacturing process of Prulifloxacin active pharmaceutical ingredient (API) in detail. Different forms of Prulifloxacin DMFs exist exist since differing nations have different regulations, such as Prulifloxacin USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Prulifloxacin DMF submitted to regulatory agencies in the US is known as a USDMF. Prulifloxacin USDMF includes data on Prulifloxacin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Prulifloxacin USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Prulifloxacin suppliers with USDMF on PharmaCompass.

Prulifloxacin JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Prulifloxacin Drug Master File in Japan (Prulifloxacin JDMF) empowers Prulifloxacin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Prulifloxacin JDMF during the approval evaluation for pharmaceutical products. At the time of Prulifloxacin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Prulifloxacin suppliers with JDMF on PharmaCompass.

Prulifloxacin GMP

Prulifloxacin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Prulifloxacin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prulifloxacin GMP manufacturer or Prulifloxacin GMP API supplier for your needs.

Prulifloxacin CoA

A Prulifloxacin CoA (Certificate of Analysis) is a formal document that attests to Prulifloxacin's compliance with Prulifloxacin specifications and serves as a tool for batch-level quality control.

Prulifloxacin CoA mostly includes findings from lab analyses of a specific batch. For each Prulifloxacin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Prulifloxacin may be tested according to a variety of international standards, such as European Pharmacopoeia (Prulifloxacin EP), Prulifloxacin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prulifloxacin USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty